OBJECTIVE: To aid in evaluating the performance of biomarkers, we measured kidney injury biomarkers in rat models of drug-induced acute kidney injury. METHODS AND RESULTS: Rats were treated with site-specific nephrotoxins, puromycin, gentamicin, cisplatin, or 2-bromoethylamine. Fifteen biomarkers (β-2-microglobulin, calbindin, clusterin, cystatin-C, KIM-1, GST-α, GST-μ, NGAL, osteopontin, EGF, TIMP-1, VEGF, albumin, RPA-1, and urinary total protein) were examined in comparison with BUN, serum creatinine, and NAG. Some biomarkers, which were different depending in each nephrotoxin, showed ability to detect the prodromal stage of drug-induced kidney injury. Characteristic changing patterns of biomarkers were also found depending on the specific lesion site in the kidney. CONCLUSION: These data suggested that establishment of a suitable biomarker panel would facilitate detection of site-specific kidney injury with high sensitivity.
OBJECTIVE: To aid in evaluating the performance of biomarkers, we measured kidney injury biomarkers in rat models of drug-induced acute kidney injury. METHODS AND RESULTS:Rats were treated with site-specific nephrotoxins, puromycin, gentamicin, cisplatin, or 2-bromoethylamine. Fifteen biomarkers (β-2-microglobulin, calbindin, clusterin, cystatin-C, KIM-1, GST-α, GST-μ, NGAL, osteopontin, EGF, TIMP-1, VEGF, albumin, RPA-1, and urinary total protein) were examined in comparison with BUN, serum creatinine, and NAG. Some biomarkers, which were different depending in each nephrotoxin, showed ability to detect the prodromal stage of drug-induced kidney injury. Characteristic changing patterns of biomarkers were also found depending on the specific lesion site in the kidney. CONCLUSION: These data suggested that establishment of a suitable biomarker panel would facilitate detection of site-specific kidney injury with high sensitivity.
Authors: Kevin J Downes; Min Dong; Tsuyoshi Fukuda; John P Clancy; Christopher Haffner; Michael R Bennett; Alexander A Vinks; Stuart L Goldstein Journal: J Antimicrob Chemother Date: 2016-09-01 Impact factor: 5.790
Authors: Omar Cauli; Alba González-Usano; Andrea Cabrera-Pastor; Carla Gimenez-Garzó; Pilar López-Larrubia; Amparo Ruiz-Sauri; Vicente Hernández-Rabaza; Malgorzata Duszczyk; Michal Malek; Jerzy W Lazarewicz; Arturo Carratalá; Amparo Urios; Alfonso Miguel; Isidro Torregrosa; Carmen Carda; Carmina Montoliu; Vicente Felipo Journal: Neuromolecular Med Date: 2013-12-13 Impact factor: 3.843
Authors: Tariq Ahmad; Keyanna Jackson; Veena S Rao; W H Wilson Tang; Meredith A Brisco-Bacik; Horng H Chen; G Michael Felker; Adrian F Hernandez; Christopher M O'Connor; Venkata S Sabbisetti; Joseph V Bonventre; F Perry Wilson; Steven G Coca; Jeffrey M Testani Journal: Circulation Date: 2018-01-19 Impact factor: 29.690
Authors: Nimesh S A Patel; Hannah L Kerr-Peterson; Michael Brines; Massimo Collino; Mara Rogazzo; Roberto Fantozzi; Elizabeth G Wood; Florence L Johnson; Muhammad M Yaqoob; Anthony Cerami; Christoph Thiemermann Journal: Mol Med Date: 2012-05-09 Impact factor: 6.354
Authors: Tom T G Nieskens; Otto Magnusson; Patrik Andersson; Magnus Söderberg; Mikael Persson; Anna-Karin Sjögren Journal: Arch Toxicol Date: 2021-05-07 Impact factor: 6.168